Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_462
Snippet: Our study revealed some variation in the coagulation factor content of LR FFP, however these changes were considered unlikely to influence the efficacy of canine FFP for factor replacement. Transfusion trials of LR FFP are warranted to assess its benefit in reducing adverse transfusion reactions in dogs with coagulopathies. The Dal blood type is a high frequency antigen associated with the production of anti-Dal antibodies, which may result in in.....
Document: Our study revealed some variation in the coagulation factor content of LR FFP, however these changes were considered unlikely to influence the efficacy of canine FFP for factor replacement. Transfusion trials of LR FFP are warranted to assess its benefit in reducing adverse transfusion reactions in dogs with coagulopathies. The Dal blood type is a high frequency antigen associated with the production of anti-Dal antibodies, which may result in ineffective transfusions or in hemolytic transfusion reactions. As for most DEA, testing for Dal remains dependant on the availability of polyclonal anti-Dal antibodies obtained following sensitization of a Dal-negative dog. In the literature, little is known on the time-course of antibodies post-transfusion, which led to the present study.
Search related documents:
Co phrase search for related documents- anti dal antibody and polyclonal anti Dal antibody: 1
- anti dal antibody and transfusion reaction: 1
- blood type and hemolytic transfusion reaction: 1
- blood type and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- blood type and transfusion reaction: 1, 2
Co phrase search for related documents, hyperlinks ordered by date